8-K - Turn Therapeutics Inc. | StockGist

Current Report Details

Event Type

Material Agreement+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement On September 30, 2025 (the “Effective Time”), the Securities Exchange Commission declared effective the registration

Material Agreement

Source Document

3.03

. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. O

Securities Modification

directors

5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On September 30, 2025, in connection with the Direct Listing, the Company filed its am

Charter Amendment

9.01

Financial Statements and Exhibits. (d) The following exhibits are being filed herewith: Exhibit No. Description 3.1 Amended and Restated Certificate of Incorpor

Exhibits Only

Exhibits (7)

10.1

EXHIBIT 10.1

10.2

EXHIBIT 10.2

10.3

EXHIBIT 10.3

10.4

EXHIBIT 10.4

3.1

EXHIBIT 3.1

3.2

EXHIBIT 3.2

8-K

FORM 8-K